Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy

ClinicalTrials.gov ID: NCT00608023

Public ClinicalTrials.gov record NCT00608023. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 4:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-blind, Randomized, Placebo-controlled Extension Study Assessing the Efficacy and Long-term Safety of a 2 mg Dose of TH9507, a GHRH Analog, in HIV Subjects With Excess Abdominal Fat Accumulation

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Assessing the Efficacy and Long-Term Safety of a 2 mg dose of TH9507, a Growth Hormone-Releasing Factor Analog, in HIV Subjects with Excess Abdominal Fat Accumulation

Study identification

NCT ID
NCT00608023
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Theratechnologies
Industry
Enrollment
263 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2007 (Type not available)
Primary completion
Oct 2008 (Actual)
Completion
Oct 2008 (Actual)
Last update posted
Sep 30, 2022

2007 – 2008

United States locations

U.S. sites
27
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294-2170 —
Body Positive Inc. Phoenix Arizona 85006 —
Somero, Michael Indio California 92201 —
UCLA School of Medicine Los Angeles California 90035 —
Office of Dr. Michael Somero Palm Springs California 92262 —
University of California San Francisco California 94110 —
Kaiser Permanente San Francisco California 94118 —
UCSF/VA Medical Center San Francisco California 94121 —
AIDS Research Alliance West Hollywood California 90069 —
Denver Public Health Department Denver Colorado 80204-4507 —
Office of Dr. Gary Richmond Fort Lauderdale Florida 33316 —
Hendry/Glades County Health Departments LaBelle Florida 33935 —
Infectious Disease Research Institute Inc. Tampa Florida 33614 —
AIDS Research Consortium Atlanta (ARCA) Atlanta Georgia 30308 —
Northern Healthcare Chicago Illinois 60657 —
Northstar Medical Chicago Illinois 60657 —
Indiana University Department of Medicine Indianapolis Indiana 46202 —
Tufts University School of Medicine Boston Massachusetts 02111 —
Massachusetts General Hospital Boston Massachusetts 02114 —
The Research Institute Springfield Massachusetts 01107 —
ID Associates Hillsborough New Jersey 08844 —
AIDS Community Research Initiative of America New York New York 10018 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27599-7215 —
University Hospitals of Cleveland Cleveland Ohio 44106 —
Central Texas Clinical Research Austin Texas 78705 —
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75232 —
Swedish Medical Center Seattle Washington 98104 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00608023, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 30, 2022 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00608023 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →